908 Devices (NASDAQ:MASS) Earns Sell (E+) Rating from Weiss Ratings

908 Devices (NASDAQ:MASS)‘s stock had its “sell (e+)” rating reissued by analysts at Weiss Ratings in a report released on Saturday,Weiss Ratings reports.

MASS has been the topic of a number of other reports. Stephens reiterated an “overweight” rating and set a $6.00 price target on shares of 908 Devices in a report on Wednesday, January 15th. Stifel Nicolaus lowered their target price on 908 Devices from $17.00 to $6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Leerink Partnrs downgraded shares of 908 Devices from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 13th. Finally, Leerink Partners restated a “market perform” rating and set a $4.00 price objective (down previously from $12.00) on shares of 908 Devices in a report on Wednesday, November 13th. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $5.33.

908 Devices Trading Up 2.8 %

NASDAQ MASS opened at $2.98 on Friday. The company has a fifty day simple moving average of $2.36 and a 200 day simple moving average of $3.49. 908 Devices has a 12-month low of $1.81 and a 12-month high of $8.50. The company has a market cap of $103.76 million, a P/E ratio of -1.68 and a beta of 0.96.

Hedge Funds Weigh In On 908 Devices

A number of large investors have recently added to or reduced their stakes in the business. SG Americas Securities LLC bought a new stake in shares of 908 Devices in the 3rd quarter worth approximately $36,000. B. Riley Wealth Advisors Inc. purchased a new stake in 908 Devices in the third quarter worth $45,000. Drive Wealth Management LLC bought a new stake in 908 Devices in the third quarter valued at $50,000. Townsquare Capital LLC purchased a new position in 908 Devices during the 3rd quarter valued at $50,000. Finally, 49 Wealth Management LLC raised its holdings in 908 Devices by 16.2% in the 3rd quarter. 49 Wealth Management LLC now owns 31,099 shares of the company’s stock worth $108,000 after purchasing an additional 4,343 shares in the last quarter. Hedge funds and other institutional investors own 88.06% of the company’s stock.

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.